EB Modifier
Erythropoietic stimulating agent (esa) administered to treat anemia due to anti-cancer radiotherapy
HCPCS modifierEB
- Description
- Erythropoietic stimulating agent (esa) administered to treat anemia due to anti-cancer radiotherapy
- Short description
- Esa, anemia, radio-induced
- Added
- January 1, 2008
- Last change
- January 1, 2008
What does the EB modifier mean?
The HCPCS Level II modifier EB means: “Erythropoietic stimulating agent (esa) administered to treat anemia due to anti-cancer radiotherapy”. Append it to a HCPCS or CPT code on the claim line when the payer’s policy calls for it; placement and payment effects are defined by each payer.
Other E modifiers
- E1 – Upper left, eyelid
- E2 – Lower left, eyelid
- E3 – Upper right, eyelid
- E4 – Lower right, eyelid
- EA – Erythropoietic stimulating agent (esa) administered to treat anemia due to anti-cancer chemotherapy
- EC – Erythropoietic stimulating agent (esa) administered to treat anemia not due to anti-cancer radiotherapy or anti-cancer chemotherapy
- ED – Hematocrit level has exceeded 39% (or hemoglobin level has exceeded 13.0 g/dl) for 3 or more consecutive billing cycles immediately prior to and including the current cycle
- EE – Hematocrit level has not exceeded 39% (or hemoglobin level has not exceeded 13.0 g/dl) for 3 or more consecutive billing cycles immediately prior to and including the current cycle
- EJ – Subsequent claims for a defined course of therapy, e.g., epo, sodium hyaluronate, infliximab
- EM – Emergency reserve supply (for esrd benefit only)
- EP – Service provided as part of medicaid early periodic screening diagnosis and treatment (epsdt) program
- ER – Items and services furnished by a provider-based, off-campus emergency department
- ET – Emergency services
- EX – Expatriate beneficiary
- EY – No physician or other licensed health care provider order for this item or service